Antirheumatic effects of humanized anti-Fas monoclonal antibody in human rheumatoid arthritis/SCID mouse chimera

Journal of Rheumatology

Volumn 29, Issue 8, 2002, Pages 1609-1614

  Matsuno, Hiroaki ^a   Yudoh, Kazuo ^a   Nakazawa, Fujio ^a   Sawai, Takashi ^a   Uzuki, Miwa ^a   Nishioka, Kusuki ^a   Yonehara, Sin ^a   Nakayama, Junichi ^a   Ohtsuki, Masahiko ^a   Kimura, Tomoatsu ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Apoptosis; Lymphocytes; Rheumatoid arthritis; Scid mouse; Treatment

Indexed keywords

FAS ANTIBODY; FAS LIGAND; FC RECEPTOR; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HFE7A; UNCLASSIFIED DRUG; ANTI FAS MONOCLONAL ANTIBODY; ANTI-FAS MONOCLONAL ANTIBODY; ANTIRHEUMATIC AGENT; FAS ANTIGEN; FASL PROTEIN, MOUSE; FASLG PROTEIN, HUMAN; MEMBRANE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARTILAGE CELL; CHIMERA; CONTROLLED STUDY; CROSS LINKING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATORY CELL; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCID MOUSE; SYNOVIOCYTE; ANIMAL; CELL CULTURE; COMBINED IMMUNODEFICIENCY; DISEASE MODEL; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; LYMPHOCYTE; MOUSE MUTANT; SYNOVITIS; SYNOVIUM; TRANSPLANTATION;

ANIMAL; ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; ANTIRHEUMATIC AGENTS; APOPTOSIS; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; CHIMERA; DISEASE MODELS, ANIMAL; HUMAN; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MEMBRANE GLYCOPROTEINS; MICE; MICE, SCID; SEVERE COMBINED IMMUNODEFICIENCY; SUPPORT, NON-U.S. GOV'T; SYNOVIAL MEMBRANE; SYNOVITIS; TRANSFECTION; ANIMALS; FAS LIGAND PROTEIN; HUMANS;

EID: 0036021123     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Treatment of RA synovitis with anti-reshaping human IL-6 receptor monoclonal antibody: Use of RA tissue implants in SCID mouse model
2. Fas ligand transfectants induce apoptosis in human rheumatoid synoviocytes
3. Apoptosis is a novel therapeutic strategy for RA. Investigations using an experimental arthritis animal model
4. A novel murine anti-human Fas monoclonal antibody which mitigates lymphadenopathy without hepatotoxity
5. Potential withdrawal of rheumatoid synovium by the induction of apoptosis using a novel in vivo model of rheumatoid arthritis
6. Reshaping human antibodies for therapy
7. Reshaping human antibodies: Grafting an antilysozyme activity
8. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines
9. Different mechanisms of synovial hyperplasia in rheumatoid arthritis and pigmented villonodular synovitis: The role of telomerase activity in synovial proliferation
10. Pharmacological effects of SA96 (bucillamine) and its metabolites as immunomodulating drugs - The disulfide structure of SA-96 metabolites plays a critical role in the pharmacological action of the drug
11. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation
12. Interleukin-11, an inducible cytokine in human articular chondrocytes and synoviocytes, stimulates the production of the tissue inhibitor of metalloproteinases
13. Time course apoptosis in collagen-induced arthritis
14. Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-1 tax transgenic mice
15. Lethal effect of the anti-Fas antibody in mice
16. Apoptosis by death factor
17. Fas/Fas ligand expression and induction of apoptosis in chondrocytes